# Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder

> **NCT02354703** · PHASE2 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 293 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02354703
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 293 (ACTUAL)
- **Last updated:** 2022-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354703, "Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02354703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*